Constitutive activities of estrogen-related receptors: Transcriptional regulation of metabolism by the ERR pathways in health and disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 9, 2015, Pages 1912-1927

  Huss, Janice M ^a   Garbacz, Wojciech G ^b   Xie, Wen ^b,c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Energy metabolism; Genetic mouse models; Mitochondria; Nuclear hormone receptors; Orphan receptors; Transcriptional regulation

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR BETA; ESTROGEN RELATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; RECEPTOR INTERACTING PROTEIN 140; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; CELL DIFFERENTIATION; ENERGY BALANCE; GENE CONTROL; GENOMICS; HEART FAILURE; HUMAN; IMMUNE RESPONSE; INSULIN RESISTANCE; LIVER METABOLISM; METABOLIC CAPACITY; METABOLIC REGULATION; MUSCLE CELL; MUSCULAR DYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOCLASTOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

MUS;

EID: 84936073972     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.06.016     Document Type: Review

References (219)

1. Deblois G., Giguere V. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nat. Rev. Cancer 2013, 13:27-36.
2. Deblois G., St-Pierre J., Giguere V. The PGC-1/ERR signaling axis in cancer. Oncogene 2013, 32:3483-3490.
3. May F.E. Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer. Cancer Manag. Res. 2014, 6:225-252.
4. Inoue S., Misawa A. Estrogen-related receptors in breast cancer and prostate cancer. Front. Endocrinol. 2015, 6.
5. Evans R.M., Mangelsdorf D.J. Nuclear receptors, RXR, and the Big Bang. Cell 2014, 157:255-266.
6. Hummasti S., Tontonoz P. Adopting new orphans into the family of metabolic regulators. Mol. Endocrinol. 2008, 22:1743-1753.
7. Giguere V., Yang N., Segui P., Evans R.M. Identification of a new class of steroid hormone receptors. Nature 1988, 331:91-94.
8. Eudy J.D., Yao S., Weston M.D., Ma-Edmonds M., Talmadge C.B., Cheng J.J., Kimberling W.J., Sumegi J. Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41. Genomics 1998, 50:382-384.
9. Hong H., Yang L., Stallcup M.R. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J. Biol. Chem. 1999, 274:22618-22626.
10. Nuclear Receptors Nomenclature C. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999, 97:161-163.
11. Chen F., Zhang Q., McDonald T., Davidoff M.J., Bailey W., Bai C., Liu Q., Caskey C.T. Identification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCR. Gene 1999, 228:101-109.
12. Heard D.J., Norby P.L., Holloway J., Vissing H. Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. Mol. Endocrinol. 2000, 14:382-392.
13. Tremblay A.M., Giguere V. The NR3B subgroup: an ovERRview. Nucl. Recept. Signal. 2007, 5:e009.
14. Lydon J.P., Power R.F., Conneely O.M. Differential modes of activation define orphan subclasses within the steroid/thyroid receptor superfamily. Gene Expr. 1992, 2:273-283.
15. Tremblay A.M., Wilson B.J., Yang X.J., Giguere V. Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif. Mol. Endocrinol. 2008, 22:570-584.
16. Vu E.H., Kraus R.J., Mertz J.E. Phosphorylation-dependent sumoylation of estrogen-related receptor alpha1. Biochemistry (Mosc) 2007, 46:9795-9804.
17. Gearhart M.D., Holmbeck S.M., Evans R.M., Dyson H.J., Wright P.E. Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. J. Mol. Biol. 2003, 327:819-832.
18. Huppunen J., Aarnisalo P. Dimerization modulates the activity of the orphan nuclear receptor ERRgamma. Biochem. Biophys. Res. Commun. 2004, 314:964-970.
19. Giguere V. The ERR in the estrogen pathway. Trends Endocrinol. Metab. 2002, 13:220-225.
20. Kraus R.J., Ariazi E.A., Farrell M.L., Mertz J.E. Estrogen-related receptor alpha 1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells. J. Biol. Chem. 2002, 277:24826-24834.
21. Yang N., Shigeta H., Shi H., Teng C.T. Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter. J. Biol. Chem. 1996, 271:5795-5804.
22. Zhang Z., Chen K., Shih J.C., Teng C.T. Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors. Mol. Endocrinol. 2006, 20:1547-1561.
23. Wilson B.J., Tremblay A.M., Deblois G., Sylvain-Drolet G., Giguere V. An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha. Mol. Endocrinol. 2010, 24:1349-1358.
24. Chen S., Zhou D., Yang C., Sherman M. Molecular basis for the constitutive activity of estrogen-related receptor alpha-1. J. Biol. Chem. 2001, 276:28465-28470.
25. Xie W., Hong H., Yang N.N., Lin R.J., Simon C.M., Stallcup M.R., Evans R.M. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Mol. Endocrinol. 1999, 13:2151-2162.
26. Kallen J., Schlaeppi J.M., Bitsch F., Filipuzzi I., Schilb A., Riou V., Graham A., Strauss A., Geiser M., Fournier B. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha. J. Biol. Chem. 2004, 279:49330-49337.
27. Greschik H., Flaig R., Renaud J.P., Moras D. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. J. Biol. Chem. 2004, 279:33639-33646.
28. Greschik H., Wurtz J.M., Sanglier S., Bourguet W., van Dorsselaer A., Moras D., Renaud J.P. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell 2002, 9:303-313.
29. Kallen J., Lattmann R., Beerli R., Blechschmidt A., Blommers M.J., Geiser M., Ottl J., Schlaeppi J.M., Strauss A., Fournier B. Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism. J. Biol. Chem. 2007, 282:23231-23239.
30. Wang L., Zuercher W.J., Consler T.G., Lambert M.H., Miller A.B., Orband-Miller L.A., McKee D.D., Willson T.M., Nolte R.T. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation. J. Biol. Chem. 2006, 281:37773-37781.
31. Jin K.S., Park J.K., Yoon J., Rho Y., Kim J.H., Kim E.E., Ree M. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators. J. Phys. Chem. B 2008, 112:9603-9612.
32. Chisamore M.J., Cunningham M.E., Flores O., Wilkinson H.A., Chen J.D. Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells. PLoS One 2009, 4:e5624.
33. Chisamore M.J., Wilkinson H.A., Flores O., Chen J.D. Estrogen-related receptor-alpha antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts. Mol. Cancer Ther. 2009, 8:672-681.
34. Willy P.J., Murray I.R., Qian J., Busch B.B., Stevens W.C., Martin R., Mohan R., Zhou S., Ordentlich P., Wei P., Sapp D.W., Horlick R.A., Heyman R.A., Schulman I.G. Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8912-8917.
35. Chao E.Y., Collins J.L., Gaillard S., Miller A.B., Wang L., Orband-Miller L.A., Nolte R.T., McDonnell D.P., Willson T.M., Zuercher W.J. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma. Bioorg. Med. Chem. Lett. 2006, 16:821-824.
36. Coward P., Lee D., Hull M.V., Lehmann J.M. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:8880-8884.
37. Zuercher W.J., Gaillard S., Orband-Miller L.A., Chao E.Y., Shearer B.G., Jones D.G., Miller A.B., Collins J.L., McDonnell D.P., Willson T.M. Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRbeta and ERRgamma. J. Med. Chem. 2005, 48:3107-3109.
38. Yu D.D., Forman B.M. Identification of an agonist ligand for estrogen-related receptors ERRbeta/gamma. Bioorg. Med. Chem. Lett. 2005, 15:1311-1313.
39. Abad M.C., Askari H., O'Neill J., Klinger A.L., Milligan C., Lewandowski F., Springer B., Spurlino J., Rentzeperis D. Structural determination of estrogen-related receptor gamma in the presence of phenol derivative compounds. J. Steroid Biochem. Mol. Biol. 2008, 108:44-54.
40. Takayanagi S., Tokunaga T., Liu X., Okada H., Matsushima A., Shimohigashi Y. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity. Toxicol. Lett. 2006, 167:95-105.
41. Tohme M., Prud'homme S.M., Boulahtouf A., Samarut E., Brunet F., Bernard L., Bourguet W., Gibert Y., Balaguer P., Laudet V. Estrogen-related receptor gamma is an in vivo receptor of bisphenol A. FASEB J. 2014, 28:3124-3133.
42. Liu X., Matsushima A., Nakamura M., Costa T., Nose T., Shimohigashi Y. Fine spatial assembly for construction of the phenol-binding pocket to capture bisphenol A in the human nuclear receptor estrogen-related receptor gamma. J. Biochem. 2012, 151:403-415.
43. Okada H., Tokunaga T., Liu X., Takayanagi S., Matsushima A., Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ. Health Perspect. 2008, 116:32-38.
44. Kim D.K., Gang G.T., Ryu D., Koh M., Kim Y.N., Kim S.S., Park J., Kim Y.H., Sim T., Lee I.K., Choi C.S., Park S.B., Lee C.H., Koo S.H., Choi H.S. Inverse agonist of nuclear receptor ERRgamma mediates antidiabetic effect through inhibition of hepatic gluconeogenesis. Diabetes 2013, 62:3093-3102.
45. Deblois G., Chahrour G., Perry M.C., Sylvain-Drolet G., Muller W.J., Giguere V. Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis. Cancer Res. 2010, 70:10277-10287.
46. Deblois G., Giguere V. Nuclear receptor location analyses in mammalian genomes: from gene regulation to regulatory networks. Mol. Endocrinol. 2008, 22:1999-2011.
47. Deblois G., Hall J.A., Perry M.C., Laganiere J., Ghahremani M., Park M., Hallett M., Giguere V. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer Res. 2009, 69:6149-6157.
48. Deblois G., Giguere V. Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease. Biochim. Biophys. Acta 2011, 1812:1032-1040.
49. Dufour C.R., Wilson B.J., Huss J.M., Kelly D.P., Alaynick W.A., Downes M., Evans R.M., Blanchette M., Giguere V. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab. 2007, 5:345-356.
50. Huss J.M., Torra I.P., Staels B., Giguere V., Kelly D.P. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell. Biol. 2004, 24:9079-9091.
51. Huss J.M., Imahashi K., Dufour C.R., Weinheimer C.J., Courtois M., Kovacs A., Giguere V., Murphy E., Kelly D.P. The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab. 2007, 6:25-37.
52. Charest-Marcotte A., Dufour C.R., Wilson B.J., Tremblay A.M., Eichner L.J., Arlow D.H., Mootha V.K., Giguere V. The homeobox protein Prox1 is a negative modulator of ERR{alpha}/PGC-1{alpha} bioenergetic functions. Genes Dev. 2010, 24:537-542.
53. Alaynick W.A., Kondo R.P., Xie W., He W., Dufour C.R., Downes M., Jonker J.W., Giles W., Naviaux R.K., Giguere V., Evans R.M. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab. 2007, 6:13-24.
54. Tremblay A.M., Dufour C.R., Ghahremani M., Reudelhuber T.L., Giguere V. Physiological genomics identifies estrogen-related receptor alpha as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway. Mol. Endocrinol. 2010, 24:22-32.
55. Finck B.N., Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 2006, 116:615-622.
56. Scarpulla R.C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 2011, 1813:1269-1278.
57. Kamei Y., Ohizumi H., Fujitani Y., Nemoto T., Tanaka T., Takahashi N., Kawada T., Miyoshi M., Ezaki O., Kakizuka A. PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:12378-12383.
58. Huss J.M., Kopp R.P., Kelly D.P. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J. Biol. Chem. 2002, 277:40265-40274.
59. Schreiber S.N., Knutti D., Brogli K., Uhlmann T., Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 2003, 278:9013-9018.
60. Sladek R., Bader J.A., Giguere V. The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol. Cell. Biol. 1997, 17:5400-5409.
61. Vega R.B., Kelly D.P. A role for estrogen-related receptor alpha in the control of mitochondrial fatty acid beta-oxidation during brown adipocyte differentiation. J. Biol. Chem. 1997, 272:31693-31699.
62. Lin J., Handschin C., Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005, 1:361-370.
63. Zhou D., Chen S. PNRC2 is a 16kDa coactivator that interacts with nuclear receptors through an SH3-binding motif. Nucleic Acids Res. 2001, 29:3939-3948.
64. Mootha V.K., Handschin C., Arlow D., Xie X., Pierre J.St., Sihag S., Yang W., Altshuler D., Puigserver P., Patterson N., Willy P.J., Schulman I.G., Heyman R.A., Lander E.S., Spiegelman B.M. Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6570-6575.
65. Schreiber S.N., Emter R., Hock M.B., Knutti D., Cardenas J., Podvinec M., Oakeley E.J., Kralli A. The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6472-6477.
66. Laganiere J., Tremblay G.B., Dufour C.R., Giroux S., Rousseau F., Giguere V. A polymorphic autoregulatory hormone response element in the human estrogen-related receptor alpha (ERRalpha) promoter dictates peroxisome proliferator-activated receptor gamma coactivator-1alpha control of ERRalpha expression. J. Biol. Chem. 2004, 279:18504-18510.
67. Arany Z., Lebrasseur N., Morris C., Smith E., Yang W., Ma Y., Chin S., Spiegelman B.M. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 2007, 5:35-46.
68. Wang L., Liu J., Saha P., Huang J., Chan L., Spiegelman B., Moore D.D. The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes. Cell Metab. 2005, 2:227-238.
69. Fritah A., Christian M., Parker M.G. The metabolic coregulator RIP140: an update. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E335-E340.
70. Castet A., Herledan A., Bonnet S., Jalaguier S., Vanacker J.M., Cavailles V. Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol. Endocrinol. 2006, 20:1035-1047.
71. Powelka A.M., Seth A., Virbasius J.V., Kiskinis E., Nicoloro S.M., Guilherme A., Tang X., Straubhaar J., Cherniack A.D., Parker M.G., Czech M.P. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J. Clin. Invest. 2006, 116:125-136.
72. Luo J., Sladek R., Carrier J., Bader J.-A., Richard D., Giguere V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor {alpha}. Mol. Cell. Biol. 2003, 23:7947-7956.
73. Seth A., Steel J.H., Nichol D., Pocock V., Kumaran M.K., Fritah A., Mobberley M., Ryder T.A., Rowlerson A., Scott J., Poutanen M., White R., Parker M. The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab. 2007, 6:236-245.
74. Fritah A., Steel J.H., Nichol D., Parker N., Williams S., Price A., Strauss L., Ryder T.A., Mobberley M.A., Poutanen M., Parker M., White R. Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function. Cardiovasc. Res. 2010, 86:443-451.
75. Webb P., Anderson C.M., Valentine C., Nguyen P., Marimuthu A., West B.L., Baxter J.D., Kushner P.J. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol. Endocrinol. 2000, 14:1976-1985.
76. Yoon H.G., Chan D.W., Huang Z.Q., Li J., Fondell J.D., Qin J., Wong J. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 2003, 22:1336-1346.
77. Yamamoto H., Williams E.G., Mouchiroud L., Canto C., Fan W., Downes M., Heligon C., Barish G.D., Desvergne B., Evans R.M., Schoonjans K., Auwerx J. NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 2011, 147:827-839.
78. Perez-Schindler J., Summermatter S., Salatino S., Zorzato F., Beer M., Balwierz P.J., van Nimwegen E., Feige J.N., Auwerx J., Handschin C. The corepressor NCoR1 antagonizes PGC-1alpha and estrogen-related receptor alpha in the regulation of skeletal muscle function and oxidative metabolism. Mol. Cell. Biol. 2012, 32:4913-4924.
79. Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M., Mangelsdorf D.J. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006, 126:789-799.
80. Bonnelye E., Vanacker J.M., Spruyt N., Alric S., Fournier B., Desbiens X., Laudet V. Expression of the estrogen-related receptor 1 (ERR-1) orphan receptor during mouse development. Mech. Dev. 1997, 65:71-85.
81. Rangwala S.M., Wang X., Calvo J.A., Lindsley L., Zhang Y., Deyneko G., Beaulieu V., Gao J., Turner G., Markovits J. Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity. J. Biol. Chem. 2010, 285:22619-22629.
82. Wende A.R., Huss J.M., Schaeffer P.J., Giguere V., Kelly D.P. PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol. Cell. Biol. 2005, 25:10684-10694.
83. Cartoni R., Leger B., Hock M.B., Praz M., Crettenand A., Pich S., Ziltener J.L., Luthi F., Deriaz O., Zorzano A., Gobelet C., Kralli A., Russell A.P. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 2005, 567:349-358.
84. Arany Z. PGC-1 coactivators and skeletal muscle adaptations in health and disease. Curr. Opin. Genet. Dev. 2008, 18:426-434.
85. Canto C., Jiang L.Q., Deshmukh A.S., Mataki C., Coste A., Lagouge M., Zierath J.R., Auwerx J. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 2010, 11:213-219.
86. Barry J.B., Giguere V. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha. Cancer Res. 2005, 65:6120-6129.
87. Chinsomboon J., Ruas J., Gupta R.K., Thom R., Shoag J., Rowe G.C., Sawada N., Raghuram S., Arany Z. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21401-21406.
88. Liu D., Hinshelwood M.M., Giguere V., Mendelson C.R. Estrogen related receptor-alpha enhances surfactant protein-A gene expression in fetal lung type II cells. Endocrinology 2006, 147:5187-5195.
89. Kim D.K., Kim Y.H., Hynx D., Wang Y., Yang K.J., Ryu D., Kim K.S., Yoo E.K., Kim J.S., Koo S.H., Lee I.K., Chae H.Z., Park J., Lee C.H., Biddinger S.B., Hemmings B.A., Choi H.S. PKB/Akt phosphorylation of ERRgamma contributes to insulin-mediated inhibition of hepatic gluconeogenesis. Diabetologia 2014, 57:2576-2585.
90. Kim D.K., Ryu D., Koh M., Lee M.W., Lim D., Kim M.J., Kim Y.H., Cho W.J., Lee C.H., Park S.B., Koo S.H., Choi H.S. Orphan nuclear receptor estrogen-related receptor gamma (ERRgamma) is key regulator of hepatic gluconeogenesis. J. Biol. Chem. 2012, 287:21628-21639.
91. Liu D., Zhang Z., Teng C.T. Estrogen-related receptor-{gamma} and peroxisome proliferator-activated receptor-{gamma} coactivator-1{alpha} regulate estrogen-related receptor-{alpha} gene expression via a conserved multi-hormone response element. J. Mol. Endocrinol. 2005, 34:473-487.
92. Inoki K., Kim J., Guan K.L. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu. Rev. Pharmacol. Toxicol. 2012, 52:381-400.
93. Shaw R.J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. (Oxf.) 2009, 196:65-80.
94. Chaveroux C., Eichner L.J., Dufour C.R., Shatnawi A., Khoutorsky A., Bourque G., Sonenberg N., Giguere V. Molecular and genetic crosstalks between mTOR and ERRalpha are key determinants of rapamycin-induced nonalcoholic fatty liver. Cell Metab. 2013, 17:586-598.
95. Cunningham J.T., Rodgers J.T., Arlow D.H., Vazquez F., Mootha V.K., Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007, 450:736-740.
96. Kaneko T., Watanabe T., Oishi M. Effect of mitochondrial protein synthesis inhibitors on erythroid differentiation of mouse erythroleukemia (Friend) cells. Mol. Cell. Biol. 1988, 8:3311-3315.
97. Moyes C.D., Mathieu-Costello O.A., Tsuchiya N., Filburn C., Hansford R.G. Mitochondrial biogenesis during cellular differentiation. Am. J. Physiol. Cell Physiol. 1997, 272:C1345-C1351.
98. Vayssiere J.L., Cordeau-Lossouarn L., Larcher J.C., Basseville M., Gros F., Croizat B. Participation of the mitochondrial genome in the differentiation of neuroblastoma cells. In Vitro Cell. Dev. Biol. 1992, 28A:763-772.
99. Feng B., Jiang J., Kraus P., Ng J.H., Heng J.C., Chan Y.S., Yaw L.P., Zhang W., Loh Y.H., Han J., Vega V.B., Cacheux-Rataboul V., Lim B., Lufkin T., Ng H.H. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat. Cell Biol. 2009, 11:197-203.
100. Luo J., Sladek R., Bader J.A., Matthyssen A., Rossant J., Giguere V. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta. Nature 1997, 388:778-782.
101. Ogawa H., Shindo N., Kumagai T., Usami Y., Shikanai M., Jonwn K., Fukuda A., Kawahara M., Sotomaru Y., Tanaka S., Arima T., Kono T. Developmental ability of trophoblast stem cells in uniparental mouse embryos. Placenta 2009, 30:448-456.
102. Chambers I., Tomlinson S.R. The transcriptional foundation of pluripotency. Development 2009, 136:2311-2322.
103. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., Wong E., Orlov Y.L., Zhang W., Jiang J., Loh Y.H., Yeo H.C., Yeo Z.X., Narang V., Govindarajan K.R., Leong B., Shahab A., Ruan Y., Bourque G., Sung W.K., Clarke N.D., Wei C.L., Ng H.H. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
104. Ivanova N., Dobrin R., Lu R., Kotenko I., Levorse J., DeCoste C., Schafer X., Lun Y., Lemischka I.R. Dissecting self-renewal in stem cells with RNA interference. Nature 2006, 442:533-538.
105. Xie C.Q., Jeong Y., Fu M., Bookout A.L., Garcia-Barrio M.T., Sun T., Kim B.H., Xie Y., Root S., Zhang J., Xu R.H., Chen Y.E., Mangelsdorf D.J. Expression profiling of nuclear receptors in human and mouse embryonic stem cells. Mol. Endocrinol. 2009, 23:724-733.
106. Festuccia N., Osorno R., Halbritter F., Karwacki-Neisius V., Navarro P., Colby D., Wong F., Yates A., Tomlinson S.R., Chambers I. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 2012, 11:477-490.
107. Gagliardi A., Mullin N.P., Ying Tan Z., Colby D., Kousa A.I., Halbritter F., Weiss J.T., Felker A., Bezstarosti K., Favaro R., Demmers J., Nicolis S.K., Tomlinson S.R., Poot R.A., Chambers I. A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. EMBO J. 2013, 32:2231-2247.
108. Liang J., Wan M., Zhang Y., Gu P., Xin H., Jung S.Y., Qin J., Wong J., Cooney A.J., Liu D., Songyang Z. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 2008, 10:731-739.
109. Uranishi K., Akagi T., Sun C., Koide H., Yokota T. Dax1 associates with Esrrb and regulates its function in embryonic stem cells. Mol. Cell. Biol. 2013, 33:2056-2066.
110. van den Berg D.L., Zhang W., Yates A., Engelen E., Takacs K., Bezstarosti K., Demmers J., Chambers I., Poot R.A. Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression. Mol. Cell. Biol. 2008, 28:5986-5995.
111. Zhang X., Zhang J., Wang T., Esteban M.A., Pei D. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. J. Biol. Chem. 2008, 283:35825-35833.
112. Percharde M., Lavial F., Ng J.H., Kumar V., Tomaz R.A., Martin N., Yeo J.C., Gil J., Prabhakar S., Ng H.H., Parker M.G., Azuara V. Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev. 2012, 26:2286-2298.
113. van der Laan S., Golfetto E., Vanacker J.M., Maiorano D. Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells. PLoS One 2014, 9:e93663.
114. van der Laan S., Tsanov N., Crozet C., Maiorano D. High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. Mol. Cell 2013, 52:366-379.
115. Korohoda W., Pietrzkowski Z., Reiss K. Chloramphenicol, an inhibitor of mitochondrial protein synthesis, inhibits myoblast fusion and myotube differentiation. Folia Histochem. Cytobiol. 1993, 31:9-13.
116. Murray J., Huss J.M. Estrogen-related receptor alpha regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway. Am. J. Physiol. Cell Physiol. 2011, 301:C630-C645.
117. Murray J., Auwerx J., Huss J.M. Impaired myogenesis in estrogen-related receptor gamma (ERRgamma)-deficient skeletal myocytes due to oxidative stress. FASEB J. 2013, 27:135-150.
118. Wang S.C., Myers S., Dooms C., Capon R., Muscat G.E. An ERRbeta/gamma agonist modulates GRalpha expression, and glucocorticoid responsive gene expression in skeletal muscle cells. Mol. Cell. Endocrinol. 2010, 315:146-152.
119. Bonnelye E., Aubin J.E. An energetic orphan in an endocrine tissue: a revised perspective of the function of estrogen receptor-related receptor alpha in bone and cartilage. J. Bone Miner. Res. 2013, 28:225-233.
120. Bonnelye E., Merdad L., Kung V., Aubin J.E. The orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J. Cell Biol. 2001, 153:971-984.
121. Rajalin A.M., Pollock H., Aarnisalo P. ERRalpha regulates osteoblastic and adipogenic differentiation of mouse bone marrow mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2010, 396:477-482.
122. Vanacker J.M., Delmarre C., Guo X., Laudet V. Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. Cell Growth Differ. 1998, 9:1007-1014.
123. Zirngibl R.A., Chan J.S., Aubin J.E. Estrogen receptor-related receptor alpha (ERRalpha) regulates osteopontin expression through a non-canonical ERRalpha response element in a cell context-dependent manner. J. Mol. Endocrinol. 2008, 40:61-73.
124. Delhon I., Gutzwiller S., Morvan F., Rangwala S., Wyder L., Evans G., Studer A., Kneissel M., Fournier B. Absence of estrogen receptor-related-alpha increases osteoblastic differentiation and cancellous bone mineral density. Endocrinology 2009, 150:4463-4472.
125. Jeong B.C., Lee Y.S., Park Y.Y., Bae I.H., Kim D.K., Koo S.H., Choi H.R., Kim S.H., Franceschi R.T., Koh J.T., Choi H.S. The orphan nuclear receptor estrogen receptor-related receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation. J. Biol. Chem. 2009, 284:14211-14218.
126. Gallet M., Saidi S., Hay E., Photsavang J., Marty C., Sailland J., Carnesecchi J., Tribollet V., Barenton B., Forcet C., Birling M.C., Sorg T., Chassande O., Cohen-Solal M., Vanacker J.M. Repression of osteoblast maturation by ERRalpha accounts for bone loss induced by estrogen deficiency. PLoS One 2013, 8:e54837.
127. Teyssier C., Gallet M., Rabier B., Monfoulet L., Dine J., Macari C., Espallergues J., Horard B., Giguere V., Cohen-Solal M., Chassande O., Vanacker J.M. Absence of ERRalpha in female mice confers resistance to bone loss induced by age or estrogen-deficiency. PLoS One 2009, 4:e7942.
128. Ishii K.A., Fumoto T., Iwai K., Takeshita S., Ito M., Shimohata N., Aburatani H., Taketani S., Lelliott C.J., Vidal-Puig A., Ikeda K. Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat. Med. 2009, 15:259-266.
129. Wei W., Wang X., Yang M., Smith L.C., Dechow P.C., Sonoda J., Evans R.M., Wan Y. PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab. 2010, 11:503-516.
130. Gallet M., Vanacker J.M. ERR receptors as potential targets in osteoporosis. Trends Endocrinol. Metab. 2010, 21:637-641.
131. Dufour C.R., Levasseur M.P., Pham N.H., Eichner L.J., Wilson B.J., Charest-Marcotte A., Duguay D., Poirier-Heon J.F., Cermakian N., Giguere V. Genomic convergence among ERRalpha, PROX1, and BMAL1 in the control of metabolic clock outputs. PLoS Genet. 2011, 7:e1002143.
132. Carrier J.C., Deblois G., Champigny C., Levy E., Giguere V. Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. J. Biol. Chem. 2004, 279:52052-52058.
133. Gantner M.L., Hazen B.C., Conkright J., Kralli A. GADD45gamma regulates the thermogenic capacity of brown adipose tissue. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:11870-11875.
134. Villena J.A., Hock M.B., Chang W.Y., Barcas J.E., Giguere V., Kralli A. Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1418-1423.
135. Byerly M.S., Al Salayta M., Swanson R.D., Kwon K., Peterson J.M., Wei Z., Aja S., Moran T.H., Blackshaw S., Wong G.W. Estrogen-related receptor beta deletion modulates whole-body energy balance via estrogen-related receptor gamma and attenuates neuropeptide Y gene expression. Eur. J. Neurosci. 2013, 37:1033-1047.
136. Byerly M.S., Swanson R.D., Wong G.W., Blackshaw S. Estrogen-related receptor beta deficiency alters body composition and response to restraint stress. BMC Physiol. 2013, 13:10.
137. Sonoda J., Laganiere J., Mehl I.R., Barish G.D., Chong L.W., Li X., Scheffler I.E., Mock D.C., Bataille A.R., Robert F., Lee C.H., Giguere V., Evans R.M. Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense. Genes Dev. 2007, 21:1909-1920.
138. Rangwala S.M., Li X., Lindsley L., Wang X., Shaughnessy S., Daniels T.G., Szustakowski J., Nirmala N.R., Wu Z., Stevenson S.C. Estrogen-related receptor [alpha] is essential for the expression of antioxidant protection genes and mitochondrial function. Biochem. Biophys. Res. Commun. 2007, 357:231-236.
139. Kim D.K., Jeong J.H., Lee J.M., Kim K.S., Park S.H., Kim Y.D., Koh M., Shin M., Jung Y.S., Kim H.S., Lee T.H., Oh B.C., Kim J.I., Park H.T., Jeong W.I., Lee C.H., Park S.B., Min J.J., Jung S.I., Choi S.Y., Choy H.E., Choi H.S. Inverse agonist of estrogen-related receptor gamma controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 2014, 20:419-424.
140. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annu. Rev. Nutr. 2006, 26:323-342.
141. Michalek R.D., Gerriets V.A., Nichols A.G., Inoue M., Kazmin D., Chang C.Y., Dwyer M.A., Nelson E.R., Pollizzi K.N., Ilkayeva O., Giguere V., Zuercher W.J., Powell J.D., Shinohara M.L., McDonnell D.P., Rathmell J.C. Estrogen-related receptor-alpha is a metabolic regulator of effector T-cell activation and differentiation. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18348-18353.
142. Alaynick W.A., Way J.M., Wilson S.A., Benson W.G., Pei L., Downes M., Yu R., Jonker J.W., Holt J.A., Rajpal D.K., Li H., Stuart J., McPherson R., Remlinger K.S., Chang C.Y., McDonnell D.P., Evans R.M., Billin A.N. ERRgamma regulates cardiac, gastric, and renal potassium homeostasis. Mol. Endocrinol. 2010, 24:299-309.
143. Liang Q., De Windt L.J., Witt S.A., Kimball T.R., Markham B.E., Molkentin J.D. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 2001, 276:30245-30253.
144. Kwon D.H., Eom G.H., Kee H.J., Nam Y.S., Cho Y.K., Kim D.K., Koo J.Y., Kim H.S., Nam K.I., Kim K.K., Lee I.K., Park S.B., Choi H.S., Kook H. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4. J. Mol. Cell. Cardiol. 2013, 65:88-97.
145. Mitra M.S., Schilling J.D., Wang X., Jay P.Y., Huss J.M., Su X., Finck B.N. Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor gamma coactivator 1alpha/estrogen related receptor axis. J. Mol. Cell. Cardiol. 2011, 51:120-128.
146. Wei Y., Peng S., Wu M., Sachidanandam R., Tu Z., Zhang S., Falce C., Sobie E.A., Lebeche D., Zhao Y. Multifaceted roles of miR-1s in repressing the fetal gene program in the heart. Cell Res. 2014, 24:278-292.
147. Rhee J., Inoue Y., Yoon J.C., Puigserver P., Fan M., Gonzalez F.J., Spiegelman B.M. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4012-4017.
148. Zhang Z., Teng C.T. Interplay between estrogen-related receptor alpha (ERRalpha) and gamma (ERRgamma) on the regulation of ERRalpha gene expression. Mol. Cell. Endocrinol. 2007, 264:128-141.
149. Herzog B., Cardenas J., Hall R.K., Villena J.A., Budge P.J., Giguere V., Granner D.K., Kralli A. Estrogen-related receptor alpha is a repressor of phosphoenolpyruvate carboxykinase gene transcription. J. Biol. Chem. 2006, 281:99-106.
150. Gaillard S., Grasfeder L.L., Haeffele C.L., Lobenhofer E.K., Chu T.M., Wolfinger R., Kazmin D., Koves T.R., Muoio D.M., Chang C.Y., McDonnell D.P. Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs. Mol. Cell 2006, 24:797-803.
151. Ranhotra H.S. Up-regulation of orphan nuclear estrogen-related receptor alpha expression during long-term caloric restriction in mice. Mol. Cell. Biochem. 2009, 332:59-65.
152. Zhu L.L., Liu Y., Cui A.F., Shao D., Liang J.C., Liu X.J., Chen Y., Gupta N., Fang F.D., Chang Y.S. PGC-1alpha coactivates estrogen-related receptor-alpha to induce the expression of glucokinase. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E1210-E1218.
153. Handschin C., Lin J., Rhee J., Peyer A.K., Chin S., Wu P.H., Meyer U.A., Spiegelman B.M. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 2005, 122:505-515.
154. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
155. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423:550-555.
156. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., Newgard C.B., Spiegelman B.M. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
157. Schmidt S.F., Mandrup S. Gene program-specific regulation of PGC-1{alpha} activity. Genes Dev. 2011, 25:1453-1458.
158. Lustig Y., Ruas J.L., Estall J.L., Lo J.C., Devarakonda S., Laznik D., Choi J.H., Ono H., Olsen J.V., Spiegelman B.M. Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase. Genes Dev. 2011, 25:1232-1244.
159. Rodgers J.T., Haas W., Gygi S.P., Puigserver P. Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic gluconeogenesis. Cell Metab. 2010, 11:23-34.
160. LaBarge S., McDonald M., Smith-Powell L., Auwerx J., Huss J.M. Estrogen-related receptor-alpha (ERRalpha) deficiency in skeletal muscle impairs regeneration in response to injury. FASEB J. 2014, 28:1082-1097.
161. Perry M.C., Dufour C.R., Tam I.S., B'Chir W., Giguere V. Estrogen-Related Receptor Alpha coordinates transcriptional programs essential for exercise tolerance and muscle fitness. Mol. Endocrinol. 2014, 28:2060-2071.
162. Narkar V.A., Fan W., Downes M., Yu R.T., Jonker J.W., Alaynick W.A., Banayo E., Karunasiri M.S., Lorca S., Evans R.M. Exercise and PGC-1alpha-independent synchronization of type I muscle metabolism and vasculature by ERRgamma. Cell Metab. 2011, 13:283-293.
163. Matsakas A., Yadav V., Lorca S., Evans R.M., Narkar V.A. Revascularization of ischemic skeletal muscle by estrogen-related receptor-gamma. Circ. Res. 2012, 110:1087-1096.
164. Duguez S., Feasson L., Denis C., Freyssenet D. Mitochondrial biogenesis during skeletal muscle regeneration. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E802-E809.
165. Fink E., Fortin D., Serrurier B., Ventura-Clapier R., Bigard A.X. Recovery of contractile and metabolic phenotypes in regenerating slow muscle after notexin-induced or crush injury. J. Muscle Res. Cell Motil. 2003, 24:421-429.
166. Wagatsuma A., Kotake N., Mabuchi K., Yamada S. Expression of nuclear-encoded genes involved in mitochondrial biogenesis and dynamics in experimentally denervated muscle. J. Physiol. Biochem. 2011, 67:359-370.
167. Wagatsuma A., Kotake N., Yamada S. Muscle regeneration occurs to coincide with mitochondrial biogenesis. Mol. Cell. Biochem. 2011, 349:139-147.
168. Handschin C., Chin S., Li P., Liu F., Maratos-Flier E., Lebrasseur N.K., Yan Z., Spiegelman B.M. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J. Biol. Chem. 2007, 282:30014-30021.
169. Nakashima K., Yakabe Y. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes. Biosci. Biotechnol. Biochem. 2007, 71:1650-1656.
170. Stupka N., Schertzer J.D., Bassel-Duby R., Olson E.N., Lynch G.S. Calcineurin-A alpha activation enhances the structure and function of regenerating muscles after myotoxic injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R686-R694.
171. Stupka N., Schertzer J.D., Bassel-Duby R., Olson E.N., Lynch G.S. Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R983-R992.
172. Wenz T., Rossi S.G., Rotundo R.L., Spiegelman B.M., Moraes C.T. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20405-20410.
173. Bolster D.R., Crozier S.J., Kimball S.R., Jefferson L.S. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 2002, 277:23977-23980.
174. Chan A.Y.M., Soltys C.-L.M., Young M.E., Proud C.G., Dyck J.R.B. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J. Biol. Chem. 2004, 279:32771-32779.
175. Fulco M., Cen Y., Zhao P., Hoffman E.P., McBurney M.W., Sauve A.A., Sartorelli V. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell 2008, 14:661-673.
176. Mounier R., Lantier L., Leclerc J., Sotiropoulos A., Pende M., Daegelen D., Sakamoto K., Foretz M., Viollet B. Important role for AMPK{alpha}1 in limiting skeletal muscle cell hypertrophy. FASEB J. 2009, 23:2264-2273.
177. Abel E.D., Doenst T. Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc. Res. 2011, 90:234-242.
178. Chen Y., Wang Y., Chen J., Chen X., Cao W., Chen S., Xu S., Huang H., Liu P. Roles of transcriptional corepressor RIP140 and coactivator PGC-1alpha in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes. Mol. Cell. Endocrinol. 2012, 362:11-18.
179. Gomez-Arroyo J., Mizuno S., Szczepanek K., Van Tassell B., Natarajan R., dos Remedios C.G., Drake J.I., Farkas L., Kraskauskas D., Wijesinghe D.S., Chalfant C.E., Bigbee J., Abbate A., Lesnefsky E.J., Bogaard H.J., Voelkel N.F. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ. Heart Fail. 2013, 6:136-144.
180. Watson P.A., Birdsey N., Huggins G.S., Svensson E., Heppe D., Knaub L. Cardiac-specific overexpression of dominant-negative CREB leads to increased mortality and mitochondrial dysfunction in female mice. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H2056-H2068.
181. Arany Z., Novikov M., Chin S., Ma Y., Rosenzweig A., Spiegelman B.M. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10086-10091.
182. Riehle C., Wende A.R., Zaha V.G., Pires K.M., Wayment B., Olsen C., Bugger H., Buchanan J., Wang X., Moreira A.B., Doenst T., Medina-Gomez G., Litwin S.E., Lelliott C.J., Vidal-Puig A., Abel E.D. PGC-1beta deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ. Res. 2011, 109:783-793.
183. Hu X., Xu X., Lu Z., Zhang P., Fassett J., Zhang Y., Xin Y., Hall J.L., Viollet B., Bache R.J., Huang Y., Chen Y. AMP activated protein kinase-alpha2 regulates expression of estrogen-related receptor-alpha, a metabolic transcription factor related to heart failure development. Hypertension 2011, 58:696-703.
184. Sihag S., Cresci S., Li A.Y., Sucharov C.C., Lehman J.J. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J. Mol. Cell. Cardiol. 2009, 46:201-212.
185. Crawford P.A., Schaffer J.E. Metabolic stress in the myocardium: adaptations of gene expression. J. Mol. Cell. Cardiol. 2013, 55:130-138.
186. Gurha P., Wang T., Larimore A.H., Sassi Y., Abreu-Goodger C., Ramirez M.O., Reddy A.K., Engelhardt S., Taffet G.E., Wehrens X.H., Entman M.L., Rodriguez A. microRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription. PLoS One 2013, 8:e75882.
187. Oka S., Zhai P., Alcendor R., Park J.Y., Tian B., Sadoshima J. Suppression of ERR targets by a PPARalpha/Sirt1 complex in the failing heart. Cell Cycle 2012, 11:856-864.
188. Palomer X., Salvado L., Barroso E., Vazquez-Carrera M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int. J. Cardiol. 2013, 168:3160-3172.
189. Cresci S., Huss J.M., Beitelshees A.L., Jones P.G., Minton M.R., Dorn G.W., Kelly D.P., Spertus J.A., McLeod H.L. A PPARalpha promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes. PLoS One 2010, 5:e12584.
190. Mistry N.F., Cresci S. PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure. Heart Fail. Rev. 2010, 15:197-207.
191. Baron D., Magot A., Ramstein G., Steenman M., Fayet G., Chevalier C., Jourdon P., Houlgatte R., Savagner F., Pereon Y. Immune response and mitochondrial metabolism are commonly deregulated in DMD and aging skeletal muscle. PLoS One 2011, 6:e26952.
192. Matsakas A., Yadav V., Lorca S., Narkar V. Muscle ERRgamma mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming. FASEB J. 2013, 27:4004-4016.
193. Jahnke V.E., Van Der Meulen J.H., Johnston H.K., Ghimbovschi S., Partridge T., Hoffman E.P., Nagaraju K. Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet. Muscle 2012, 2:16.
194. Ljubicic V., Miura P., Burt M., Boudreault L., Khogali S., Lunde J.A., Renaud J.M., Jasmin B.J. Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle. Hum. Mol. Genet. 2011, 20:3478-3493.
195. Patch R.J., Searle L.L., Kim A.J., De D., Zhu X., Askari H.B., O'Neill J.C., Abad M.C., Rentzeperis D., Liu J., Kemmerer M., Lin L., Kasturi J., Geisler J.G., Lenhard J.M., Player M.R., Gaul M.D. Identification of diaryl ether-based ligands for estrogen-related receptor alpha as potential antidiabetic agents. J. Med. Chem. 2011, 54:788-808.
196. Aatsinki S.M., Buler M., Salomaki H., Koulu M., Pavek P., Hakkola J. Metformin induces PGC-1alpha expression and selectively affects hepatic PGC-1alpha functions. Br. J. Pharmacol. 2014, 171:2351-2363.
197. Kim D.K., Kim J.R., Koh M., Kim Y.D., Lee J.M., Chanda D., Park S.B., Min J.J., Lee C.H., Park T.S., Choi H.S. Estrogen-related receptor gamma (ERRgamma) is a novel transcriptional regulator of phosphatidic acid phosphatase, LIPIN1, and inhibits hepatic insulin signaling. J. Biol. Chem. 2011, 286:38035-38042.
198. Kim J.K., Fillmore J.J., Sunshine M.J., Albrecht B., Higashimori T., Kim D.W., Liu Z.X., Soos T.J., Cline G.W., O'Brien W.R., Littman D.R., Shulman G.I. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 2004, 114:823-827.
199. Schmitz-Peiffer C., Browne C.L., Oakes N.D., Watkinson A., Chisholm D.J., Kraegen E.W., Biden T.J. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997, 46:169-178.
200. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., Shulman G.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 2002, 277:50230-50236.
201. Lu N., Wang W., Liu J., Wong C.W. Protein kinase C epsilon affects mitochondrial function through estrogen-related receptor alpha. Cell. Signal. 2011, 23:1473-1478.
202. Koves T.R., Ussher J.R., Noland R.C., Slentz D., Mosedale M., Ilkayeva O., Bain J., Stevens R., Dyck J.R., Newgard C.B., Lopaschuk G.D., Muoio D.M. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008, 7:45-56.
203. Muoio D.M., Newgard C.B. Obesity-related derangements in metabolic regulation. Annu. Rev. Biochem. 2006, 75:367-401.
204. Seiler S.E., Martin O.J., Noland R.C., Slentz D.H., Debalsi K.L., Ilkayeva O.R., An J., Newgard C.B., Koves T.R., Muoio D.M. Obesity and lipid stress inhibit carnitine acetyltransferase activity. J. Lipid Res. 2014, 55:635-644.
205. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
206. Lowell B.B., Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307:384-387.
207. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8466-8471.
208. Toledo F.G. Mitochondrial involvement in skeletal muscle insulin resistance. Diabetes 2014, 63:59-61.
209. Egan B., Zierath J.R. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 2013, 17:162-184.
210. LeBrasseur N.K., Walsh K., Arany Z. Metabolic benefits of resistance training and fast glycolytic skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E3-E10.
211. Koves T.R., Li P., An J., Akimoto T., Slentz D., Ilkayeva O., Dohm G.L., Yan Z., Newgard C.B., Muoio D.M. Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. 2005, 280:33588-33598.
212. Li L., Pan R., Li R., Niemann B., Aurich A.C., Chen Y., Rohrbach S. Mitochondrial biogenesis and peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) deacetylation by physical activity: intact adipocytokine signaling is required. Diabetes 2011, 60:157-167.
213. Baar K., Wende A.R., Jones T.E., Marison M., Nolte L.A., Chen M., Kelly D.P., Holloszy J.O. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J. 2002, 16:1879-1886.
214. Lira V.A., Benton C.R., Yan Z., Bonen A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E145-E161.
215. Lin J., Wu H., Tarr P.T., Zhang C.Y., Wu Z., Boss O., Michael L.F., Puigserver P., Isotani E., Olson E.N., Lowell B.B., Bassel-Duby R., Spiegelman B.M. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002, 418:797-801.
216. Summermatter S., Shui G., Maag D., Santos G., Wenk M.R., Handschin C. PGC-1alpha improves glucose homeostasis in skeletal muscle in an activity-dependent manner. Diabetes 2013, 62:85-95.
217. Narkar V.A., Downes M., Yu R.T., Embler E., Wang Y.X., Banayo E., Mihaylova M.M., Nelson M.C., Zou Y., Juguilon H., Kang H., Shaw R.J., Evans R.M. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008, 134:405-415.
218. Chao L.C., Wroblewski K., Ilkayeva O.R., Stevens R.D., Bain J., Meyer G.A., Schenk S., Martinez L., Vergnes L., Narkar V.A., Drew B.G., Hong C., Boyadjian R., Hevener A.L., Evans R.M., Reue K., Spencer M.J., Newgard C.B., Tontonoz P. Skeletal muscle Nur77 expression enhances oxidative metabolism and substrate utilization. J. Lipid Res. 2012, 53:2610-2619.
219. Perez-Schindler J., Svensson K., Vargas-Fernandez E., Santos G., Wahli W., Handschin C. The coactivator PGC-1alpha regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARbeta/delta in sedentary mice fed a regular chow diet. Diabetologia 2014, 57:2405-2412.